Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Clinical Study of Ecopipam in Pediatric Tourette Syndrome (TS) Patients

Trial Profile

A Clinical Study of Ecopipam in Pediatric Tourette Syndrome (TS) Patients

Planning
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2018

At a glance

  • Drugs Ecopipam (Primary)
  • Indications Gilles de la Tourette's syndrome
  • Focus Therapeutic Use
  • Sponsors Emalex Biosciences
  • Most Recent Events

    • 29 Aug 2018 New trial record
    • 14 Aug 2018 According to an Emalex Biosciences media release, the company will initiate this larger clinical study in early 2019, with results expected in 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top